Hepatitis B Virus Proteins Eliciting Protective Immunity
Overview
Authors
Affiliations
The immune response to current hepatitis B vaccines appears to be qualitatively different from the response elicited during recovery from natural infection. Such disparate responses can probably be explained by the absence or under-representation of preS- and the nucleoprotein core-specific determinants in the vaccines. The incorporation of these determinants into future vaccines may improve their efficacy.
Gregoriadis G, Wang Z, Barenholz Y, Francis M Immunology. 1993; 80(4):535-40.
PMID: 7508417 PMC: 1422236.
Hu K, Hao L, Zhang Y, Schaller H J Tongji Med Univ. 1989; 9(1):8-12.
PMID: 2760966 DOI: 10.1007/BF02933736.
Chu C, Liaw Y Gut. 1992; 33(11):1544-8.
PMID: 1452081 PMC: 1379543. DOI: 10.1136/gut.33.11.1544.
Heterologous protein production in yeast.
Gellissen G, Melber K, Janowicz Z, Dahlems U, Weydemann U, Piontek M Antonie Van Leeuwenhoek. 1992; 62(1-2):79-93.
PMID: 1444338 DOI: 10.1007/BF00584464.